Acute neurological alterations have been associated with SARS-CoV-2 infection.
Additionally, it is becoming clear that coronavirus disease 2019 (COVID-19) survivors may …

Background Over the past few years, mesenchymal stromal cells (MSCs) have attracted a
great deal of scientific attention owing to their promising results in the treatment of incurable …

Background Despite widespread acceptance that neuroinflammation contributes to age-
related cognitive decline, studies comparing protein expression of cytokines in the young …

The increase of Angiontesin-II (Ang-II), one of the key peptides of the renin-angiotensin
system (RAS), and its binding to the Ang-II type 1 receptor (AT1R) during hypertension is a …

Autoimmune neuroinflammatory diseases are a group of disorders resulting from abnormal
immune responses in the nervous system, causing inflammation and tissue damage. The …

Alzheimer's disease (AD) is an age-related and progressive neurodegenerative disorder. It
is widely accepted that AD is mainly caused by the accumulation of extracellular amyloid β …

Neurological degeneration after neuroinflammation, such as that resulting from Alzheimer's
disease (AD), stroke, multiple sclerosis (MS), and post-traumatic brain injury (TBI), is …

Neuropsychiatric symptoms, such as anxiety and depression often appear early in patients
with Alzheimer's disease (AD), and a comorbid, anxiety-like phenotype is also found in …

Short chain fatty acids (SCFAs) are known to be actively involved in multiple brain disorders,
but their roles in sepsis-associated encephalopathy (SAE) remain unclear. Here, we …

Background Low-grade, chronic inflammation in the central nervous system characterized
by glial reactivity is one of the major hallmarks for aging-related neurodegenerative …